Literature DB >> 28831302

Cutaneous infection and bactaeremia caused by Erwinia billingiae: a case report.

M Prod'homme1, L A Micol1, S Weitsch1, J-L Gassend1, O Martinet1, C Bellini2.   

Abstract

Cellulitis and erysipelas are common skin infections usually caused by Staphylococcus aureus and streptococci. Gram-negative rods are rarely implicated. We report here a case of dermohypodermitis and bactaeremia caused by Erwinia billingiae, a Gram-negative bacteria usually pathogenic and epiphytic to pome fruit tree.

Entities:  

Keywords:  Bloodstream infection; Erwinia billingiae; dermohypodermitis; erysipelas; lymphangitis

Year:  2017        PMID: 28831302      PMCID: PMC5555272          DOI: 10.1016/j.nmni.2017.07.006

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


Introduction

Acute bacterial skin infections like cellulitis and erysipelas are common skin infections, with an incidence rate of 1/1000 per year [1]. They are usually caused by aerobic Gram-positive bacteria, such as Staphylococcus aureus and group A β-haemolytic streptococci, and only rarely by Gram-negative bacteria such as Pseudomonas aeruginosa and other enterobacteria (i.e. Klebsiella spp., Proteus mirabilis) [2], [3], [4], [5]. Common risk factors include lymphoedema, disruption of the cutaneous barrier and toe–web intertrigo [6]. Blood cultures are positive in about 5 to 10% of cases [5], [7]. Erwinia billingiae is a Gram-negative bacteria belonging to the Enterobacteriaceae family which is usually pathogenic to plants [8]. Human infections by Erwinia-like microorganisms are rarely described. The first case reported in the literature was that of an 88-year-old woman with a urinary tract infection related to Erwinia persicinus [9]. The second case concerned a 79-year-old woman with cervical lymphadenitis caused by an Erwinia tasmaniensis–like organism [10].

Case presentation

In July 2015, a 40-year-old man with known chronic hepatitis C sought care at our emergency department with a painful redness of his third right toe which was rapidly spreading to the back of his foot. It had appeared the previous day after a barefoot walk in the grass. He did not complain of shivering or fever. There was no history of clear trauma or insect bite. Examination revealed a painful, diffuse oedema and redness of his third toe and the back of his foot (Fig. 1A), compatible with dermohypodermitis and associated with lymphangitic streaking up to the medial calf (Fig. 1B), as well as painful and swollen popliteal and inguinal lymph nodes. The interdigital space showed lesions suggestive of intertrigo. He did not manifest other local or general symptoms.
Fig. 1

Initial clinical presentation. (A) Redness of third toe and over back of foot. (B) Lymphangitic redness up to medial calf (marked in blue).

Initial clinical presentation. (A) Redness of third toe and over back of foot. (B) Lymphangitic redness up to medial calf (marked in blue). Conventional X-rays of the foot did not reveal an underlying bone injury or the presence of foreign bodies. Blood culture samples and skin squames were collected. According to local guidelines, an empiric antibiotic treatment with amoxicillin–clavulanic acid (first dose 2.2 g iv followed by 1 g twice a day orally) was started [1], [10]. In addition, the patient's right leg and foot were immobilized in a posterior cast. We prescribed once-daily thromboprophylaxis with subcutaneous dalteparin sodium 5000 IU and a systemic nonsteroidal anti-inflammatory drug (ibuprofen) with no weight bearing permitted. One out of two pairs of blood cultures grew Erwinia billingiae. Antibiogram revealed resistance to all β-lactam antibiotics except carbapenems, intermediary resistance to gentamicin, and sensitivity to ciprofloxacin and cotrimoxazole. Furthermore, the local samples of his intertoe compartments revealed the presence of the dermatophyte Trichophyton rubrum. Because of the results of the susceptibility testing, antibiotic treatment was changed to oral ciprofloxacin 500 mg twice daily and continued for 14 days. Further clinical evolution was favourable: the patient did not report any additional fever, and the local redness, oedema and pain rapidly resolved. At follow-up 2 months later, the patient remained asymptomatic and without any sequelae.

Discussion

To our knowledge, this is the first case of human infection caused by Erwinia billingiae reported in the literature. Erwinia billingiae is a Gram-negative bacterial strain belonging to the Enterobacteriaceae family, first described in 1999 [11]. Species in this genus are similar to Pantoea and Enterobacter species, and many Erwinia species have been reclassified into these groups [8], [12]. Usually Erwinia species are plant-associated bacteria, pathogenic or not [13], [14], [15]. Pathogenic species like Erwinia amylovora and Erwinia pyrifoliae are connected with so-called pome fruit diseases (i.e. the fire blight of apples), while species like E. tasmaniensis and E. billingiae are rather epiphytic, nonpathogenic bacteria [16]. Clinical isolates of Erwinia spp. are rare: Erwinia persicina was isolated from the urine of a woman with a urinary tract infection [9], and E. tasmaniensis was found in a biopsy tissue sample of cervical lymphadenitis [10]. Other case reports describe Erwinia spp. as a possible causative agent of urinary tract infections [17]. However, it is not clear if the organism actually caused the infection. In the present case the patient exhibited dermohypodermitis associated with bloodstream infection due to Erwinia billingiae. Our hypothesis is that the interdigital intertrigo and the barefoot walk in a grassy field were the risk factors for this infection. Even if a skin biopsy demonstrating bacterial growth was not performed, the favourable clinical course after receipt of directed antibiotic therapy suggests a possible implication of this Erwinia strain as an opportunistic agent in this infection.

Conflict of interest

None declared.
  16 in total

1.  Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples.

Authors:  J D Semel; H Goldin
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 2.  A systematic review of bacteremias in cellulitis and erysipelas.

Authors:  Craig G Gunderson; Richard A Martinello
Journal:  J Infect       Date:  2011-11-11       Impact factor: 6.072

3.  First report of a human isolate of Erwinia persicinus.

Authors:  C M O'Hara; A G Steigerwalt; B C Hill; J M Miller; D J Brenner
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis.

Authors:  J Carratalà; B Rosón; N Fernández-Sabé; E Shaw; O del Rio; A Rivera; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

5.  Genome comparison of the epiphytic bacteria Erwinia billingiae and E. tasmaniensis with the pear pathogen E. pyrifoliae.

Authors:  Michael Kube; Alexander M Migdoll; Isabel Gehring; Katja Heitmann; Yvonne Mayer; Heiner Kuhl; Florian Knaust; Klaus Geider; Richard Reinhardt
Journal:  BMC Genomics       Date:  2010-06-22       Impact factor: 3.969

Review 6.  Acute bacterial skin infections and cellulitis.

Authors:  Marion Gabillot-Carré; Jean-Claude Roujeau
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

7.  Phylogenetic position of phytopathogens within the Enterobacteriaceae.

Authors:  L Hauben; E R Moore; L Vauterin; M Steenackers; J Mergaert; L Verdonck; J Swings
Journal:  Syst Appl Microbiol       Date:  1998-08       Impact factor: 4.022

8.  New Erwinia-like organism causing cervical lymphadenitis.

Authors:  Sang Yop Shin; Mi Young Lee; Jae-Hoon Song; Kwan Soo Ko
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

9.  Reclassification of non-pigmented Erwinia herbicola strains from trees as Erwinia billingiae sp. nov.

Authors:  J Mergaert; L Hauben; M C Cnockaert; J Swings
Journal:  Int J Syst Bacteriol       Date:  1999-04

10.  Erysipelas, a large retrospective study of aetiology and clinical presentation.

Authors:  Anna Bläckberg; Kristina Trell; Magnus Rasmussen
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

View more
  5 in total

1.  A genome-wide analysis of desferrioxamine mediated iron uptake in Erwinia spp. reveals genes exclusive of the Rosaceae infecting strains.

Authors:  Ivan Polsinelli; Luigimaria Borruso; Rosanna Caliandro; Luca Triboli; Alfonso Esposito; Stefano Benini
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

2.  Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.

Authors:  Taraprasad Das; Rajagopalaboopathi Jayasudha; SamaKalyana Chakravarthy; Gumpili Sai Prashanthi; Archana Bhargava; Mudit Tyagi; Padmaja Kumari Rani; Rajeev Reddy Pappuru; Savitri Sharma; Sisinthy Shivaji
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

3.  Explainable AI reveals changes in skin microbiome composition linked to phenotypic differences.

Authors:  Anna Paola Carrieri; Niina Haiminen; Sean Maudsley-Barton; Laura-Jayne Gardiner; Barry Murphy; Andrew E Mayes; Sarah Paterson; Sally Grimshaw; Martyn Winn; Cameron Shand; Panagiotis Hadjidoukas; Will P M Rowe; Stacy Hawkins; Ashley MacGuire-Flanagan; Jane Tazzioli; John G Kenny; Laxmi Parida; Michael Hoptroff; Edward O Pyzer-Knapp
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

4.  Proteomics-based identification of orchid-associated bacteria colonizing the Epipactis albensis, E. helleborine and E. purpurata (Orchidaceae, Neottieae).

Authors:  Anna Jakubska-Busse; Anna Kędziora; Gabriela Cieniuch; Agnieszka Korzeniowska-Kowal; Gabriela Bugla-Płoskońska
Journal:  Saudi J Biol Sci       Date:  2021-04-20       Impact factor: 4.219

Review 5.  Drosophila as a Model for Infectious Diseases.

Authors:  J Michael Harnish; Nichole Link; Shinya Yamamoto
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.